VANCOUVER, Dec. 18, 2013 /CNW/ - David H. Brett, CEO, Inovent Capital
Inc. (the "Company"), a Capital Pool Company, is pleased to announce
that on December 18, 2013, the Company successfully completed its
initial public offering (the "Offering"). The Company's common were
listed for trading today on the TSX Venture Exchange under the trading
Inovent issued 2,564,800 common shares (the "Shares") for gross proceeds
of $256,480 through the Company's agent, Euro Pacific Canada Inc. (the
"Agent"). In connection with the Offering, the Agent received a cash
commission equal to 10% of the gross proceeds of the Offering. In
addition, the Company granted to the Agent a non-transferable warrant
to purchase up to 256,480 shares at a price of $0.10 per share which
may be exercised for a period of 24 months from today. The Agent was
also paid a corporate finance fee for its services in connection with
"Inovent's seasoned board brings decades of business experience to
fulfilling our mission, which is to identify a qualifying transaction
that has the potential to provide excellent returns to shareholders,"
said Inovent CEO David H. Brett. "Our initial focus will be to find
exciting opportunities in technology and life sciences."
The board of directors of the Company consists of David H. Brett, George
A. Pietrobon, Ari M. Shack, John Gomez and Robert J. Baylis.
On behalf of the board of INOVENT CAPITAL INC.
Per: "David Brett"
David H. Brett, MBA
Chief Executive Officer & Director
Investors are cautioned that trading in the securities of a capital pool
company should be considered highly speculative. The TSX Venture exchange has not reviewed and does not accept
responsibility for the accuracy or adequacy of this release.
SOURCE: Inovent Capital Inc.
For further information:
Chief Executive Officer